Influence of antiestrogens on EGF- and IGF-I-mediated proliferation of human breast cancer cells [7]

In Vitro Cellular and Developmental Biology - Animal

Volumn 35, Issue 1, 1999, Pages 19-21

  Tong, G M ^a   Rajah, T T ^a   Pento, J T ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; EPIDERMAL GROWTH FACTOR; ESTROGEN; SOMATOMEDIN C;

BREAST CANCER; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; LETTER;

EID: 0032933968     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-999-0039-z     Document Type: Letter

References (17)

1. 1. S. F. Arnold J. D. Obourn H. Jaffe 1995 Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro Mol. Endocrinol. 9 24 33 7539106 10.1210/me.9.1.24 1:CAS:528:DyaK2MXjsFGhsr4%3D Arnold, S. F.; Obourn, J. D.; Jaffe, H., et al. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Mol. Endocrinol. 9:24–33; 1995.
2. 2. H. Babich E. Borenfreund 1987 Structure-activity relationship (SAR) models established in vitro with the neutral red cytotoxicity assay Toxicol. In Vitro 1 3 8 10.1016/0887-2333(87)90031-2 1:CAS:528:DyaL2sXhtlehsLo%3D 20702372 Babich, H.; Borenfreund, E. Structure-activity relationship (SAR) models established in vitro with the neutral red cytotoxicity assay. Toxicol. In Vitro 1:3–8; 1987.
3. 3. C. Charlier A. Chariot N. Antoine 1995 Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells Biochem. Pharmacol. 49 351 358 7857322 10.1016/0006-2952(94)00492-5 1:CAS:528:DyaK2MXjslegt70%3D Charlier, C.; Chariot, A.; Antoine, N., et al. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem. Pharmacol. 49:351–358; 1995.
4. 4. E. M. Cormier V. C. Jordan 1989 Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol of epidermal growth factor Eur. J. Cancer. Clin. Oncol. 25 57 63 2784101 10.1016/0277-5379(89)90051-5 1:CAS:528:DyaL1MXht1yrsrs%3D Cormier, E. M.; Jordan, V. C. Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol of epidermal growth factor. Eur. J. Cancer. Clin. Oncol. 25:57–63; 1989.
5. 5. G. Freiss H. Rochefort F. Vignon 1990 Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity Biochem. Biophys. Res. Commun. 13 919 925 10.1016/S0006-291X(05)80873-3 Freiss, G.; Rochefort, H.; Vignon, F. Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem. Biophys. Res. Commun. 13:919–925; 1990.
6. 6. H. T. Huynh M. Pollak 1993 Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182,780 Cancer Res. 53 5585 5588 8242606 1:CAS:528:DyaK2cXksFeqtQ%3D%3D Huynh, H. T.; Pollak, M. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182,780. Cancer Res. 53:5585–5588; 1993.
7. 7. D. M. Ignar-Trowbridge K. G. Nelson M. C. Bidwell 1992 Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor Proc. Natl. Acad. Sci. USA 89 4658 4662 1584801 10.1073/pnas.89.10.4658 1:CAS:528:DyaK38XktVWhtrc%3D Ignar-Trowbridge, D. M.; Nelson, K. G.; Bidwell, M. C., et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. USA 89:4658–4662; 1992.
8. 8. P. T. Jain T. T. Rajah J. T. Pento 1997 Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells Anti-Cancer Drugs 8 964 975 9436640 1:CAS:528:DyaK1cXislWktQ%3D%3D 10.1097/00001813-199711000-00008 Jain, P. T.; Rajah, T. T.; Pento, J. T. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells. Anti-Cancer Drugs 8:964–975; 1997.
9. 9. K. P. Karey D. A. Sirbasku 1988 Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol Cancer Res. 48 4083 4092 3289739 1:CAS:528:DyaL1cXkvVKqtrw%3D Karey, K. P.; Sirbasku, D. A. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res. 48:4083–4092; 1988.
10. 10. R. McCague M. G. Rowlands R. Grimshaw 1994 Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues Biochem. Pharmacol. 48 1355 1361 7945433 10.1016/0006-2952(94)90557-6 1:CAS:528:DyaK2MXhslSgtL8%3D McCague, R.; Rowlands, M. G.; Grimshaw, R., et al. Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues. Biochem. Pharmacol. 48:1355–1361; 1994.
11. 11. C. J. Newton R. Buric T. Trapp 1994 The unliganded estrogen receptor (ER) transduces growth factor signals J. Steroid Biochem. Mol. Biol. 48 481 486 8180109 10.1016/0960-0760(94)90197-X 1:CAS:528:DyaK2cXjtFKisb4%3D Newton, C. J.; Buric, R.; Trapp, T., et al. The unliganded estrogen receptor (ER) transduces growth factor signals. J. Steroid Biochem. Mol. Biol. 48:481–486; 1994.
12. 12. C. K. Osborne B. Hamilton G. Titus 1980 EGF stimulation of human breast cancer cells in culture Cancer Res. 40 2361 2366 6966967 1:CAS:528:DyaL3cXkvV2it7s%3D Osborne, C. K.; Hamilton, B.; Titus, G., et al. EGF stimulation of human breast cancer cells in culture. Cancer Res. 40:2361–2366; 1980.
13. 13. J. T. Pento T. T. Rajah G. M. Hurt 1995 Influence of antiestrogens and growth factors on the invasiveness of breast cancer cells in culture J. Cell. Biochem. S19B 413 413 Pento, J. T.; Rajah, T. T.; Hurt, G. M. Influence of antiestrogens and growth factors on the invasiveness of breast cancer cells in culture. J. Cell. Biochem. S19B:413; 1995.
14. 14. R. L. Sutherland M. D. Green R. E. Hall 1983 Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G 0 /G 1 phase of the cell cycle Eur. J. Cancer Clin. Oncol. 19 615 621 6683633 10.1016/0277-5379(83)90177-3 1:CAS:528:DyaL3sXktlart74%3D Sutherland, R. L.; Green, M. D.; Hall, R. E., et al. Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G 0 /G 1 phase of the cell cycle. Eur. J. Cancer Clin. Oncol. 19:615–621; 1983.
15. 15. F. Vignon M. M. Bouton H. Rochefort 1987 Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens Biochem. Biophys. Res. Commun. 146 1502 1508 3304294 10.1016/0006-291X(87)90819-9 1:CAS:528:DyaL2sXlt1OnsLk%3D Vignon, F.; Bouton, M. M.; Rochefort, H. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem. Biophys. Res. Commun. 146:1502–1508; 1987.
16. 16. M. Wagner M. T. Benson I. G. Rennie 1995 Effects of pharmacological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins Curr. Eye Res. 14 373 378 7648863 1:STN:280:DyaK2Mzns12ltA%3D%3D Wagner, M.; Benson, M. T.; Rennie, I. G., et al. Effects of pharmacological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins. Curr. Eye Res. 14:373–378; 1995.
17. 17. C. K. W. Watts R. L. Sutherland 1984 High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver Biochem. Biophys. Res. Comm. 120 109 115 6712683 10.1016/0006-291X(84)91420-7 1:CAS:528:DyaL2cXhs1ymtbc%3D Watts, C. K. W.; Sutherland, R. L. High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver. Biochem. Biophys. Res. Comm. 120:109–115; 1984.